about
Altered hematopoiesis in mice lacking DNA polymerase mu is due to inefficient double-strand break repairHematopoietic dysfunction in a mouse model for Fanconi anemia group D1In vitro and in vivo susceptibility of mouse megakaryocytic progenitors to strain i of parvovirus minute virus of mice.Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzymeCell fusion reprogramming leads to a specific hepatic expression pattern during mouse bone marrow derived hepatocyte formation in vivo.Reticulocyte-prone malaria parasites predominantly invade CD71hi immature cells: implications for the development of an in vitro culture for Plasmodium vivax.Parvovirus infection suppresses long-term repopulating hematopoietic stem cellsCardiac Bmi1(+) cells contribute to myocardial renewal in the murine adult heartConstitutively active Akt induces ectodermal defects and impaired bone morphogenetic protein signalingEvolution to pathogenicity of the parvovirus minute virus of mice in immunodeficient mice involves genetic heterogeneity at the capsid domain that determines tropism.New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cellsA comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network.Peritoneal repairing cells: a type of bone marrow derived progenitor cells involved in mesothelial regenerationA cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts.Engraftment and in vivo proliferation advantage of gene corrected mobilized CD34(+) cells from Fanconi anemia patients.Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients.Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia.Immunoresponse against the transgene limits hematopoietic engraftment of mice transplanted in utero with virally transduced fetal liver.Yohimbine prevents the effect of morphine on the redox status of neuroblastomaxglioma NG108-15 cells.Functional analysis of gammaretroviral vector transduction by quantitative PCR.Optimising stable retroviral transduction of primary human synovial fibroblasts.Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model.Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis.Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.Transplantation of syngenic bone marrow contaminated with NGFr-marked WEHI-3B cells: an improved model of leukemia relapse in mice.p73 plays a role in erythroid differentiation through GATA1 induction.Latent hematopoietic stem cell toxicity associated with protracted drug administration.In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1.Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.In vitro and in vivo expression of human erythrocyte pyruvate kinase in erythroid cells: a gene therapy approach.Cytotoxic infection of hematopoietic stem and committed progenitor cells by the parvovirus minute virus of mice. Propagation of an acute myelosuppression in culture.A simplified approach to improve the efficiency and safety of ex vivo hematopoietic gene therapy in fanconi anemia patients.Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy.Nonviral transfer of genes to pig primary keratinocytes. Induction of angiogenesis by composite grafts of modified keratinocytes overexpressing VEGF driven by a keratin promoter.Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: a weak and efficient promoter for gene therapy.Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice.IGF-I mediates regeneration of endocrine pancreas by increasing beta cell replication through cell cycle protein modulation in mice.Efficient engraftment of in utero transplanted mice with retrovirally transduced hematopoietic stem cells.Non-homologous end-joining defect in fanconi anemia hematopoietic cells exposed to ionizing radiation.
P50
Q21145008-97CCFBBE-ED7A-4B85-B9A7-245668BFFA9AQ28585929-33F40399-32B6-43BC-94CC-2CE9A05A477EQ33339676-77FC3FE4-CC6A-4FFF-9A63-BEB7B7B9F88AQ33622730-5C4DA9F7-12F2-4AE4-90DB-8FA7D2E115F5Q34212061-D79439F1-ED61-473C-B10F-300711C6E967Q34454747-F87F3C04-C105-400E-9B45-ED59A0C5E634Q35155102-75F096AF-38FB-4DC2-A209-89D4B9FA17AAQ36206492-6FCE4192-A5A9-43EC-93AE-8F32D7B5CE9EQ36325901-19A3808C-F8AA-454E-A218-72093D6FC008Q36424135-9AE2DE2B-F438-4576-B2E5-E3D7CE1459A1Q36945734-0798FBC7-B982-466F-BA45-0408AD87B130Q37004779-EA17E811-92E2-4929-9ADB-295655F8AA0DQ37294086-651291B6-AA00-43A1-8AE1-42ACCDF79A72Q38299463-88910B39-93A6-4DB1-8715-6DDDDDB2A93DQ38628205-852377CC-E8E4-4F9D-96F4-A34803942BDFQ39508334-4F7C7EEB-808A-452E-BDA7-76232CDF814EQ39764994-4380D3A5-CE34-4DF0-AE6D-DA70F5FF1541Q39802414-2F709A8E-4EBE-4CA4-8F8A-0F294B604E9BQ39845923-44F475D9-8431-41FC-9383-D68D8FB2826DQ40250341-862758FA-7A75-4240-A151-EC305EA68A12Q40256081-061E4E7D-9F60-48C9-8718-CFCAA8EE5372Q40394357-350E63CF-99F3-4F4A-919E-7CC23B8183BEQ40567182-9FFCFBBD-7DC8-46EE-80E7-C2AD032602C3Q40600845-3A232F32-B4EE-4827-A542-2A9BB376AD1BQ40694264-734F4F07-776C-468E-9D47-20A236F7EA26Q40893619-A275E5AB-2D9D-46E3-8384-EAD13E154F6CQ42575247-AE0C59D1-2830-4D05-ABFA-DFE08C308256Q43557094-6185BD93-E87B-4181-B9B0-166A7BB3E31DQ43933008-9E8D997D-7553-4C1F-8A50-0F8A1CF01A62Q44527623-1F996A18-54D0-4B71-AA10-56F523E9F71DQ44928994-C8A0245D-7E2D-4699-9BA0-929076EE9931Q45852546-5C81C62E-AE37-438F-A39B-C32367878F28Q45855712-92834186-FF63-487C-B469-F3A5B0A9463EQ45861515-EC6483D5-47E0-4B73-B11F-BB0DD175DC02Q45862819-6217A6DB-D0AA-4678-832A-0AAF7EDB86E8Q45868501-77142798-3592-4FBF-8ADF-9D4D2FCAF1F6Q45874102-6F25A12E-17EA-48BD-8BB0-1BC54855BDE0Q45879291-E5AD16B3-F9F8-4A72-804A-F1F0F8DD8355Q45879533-0E7E1CF4-89EE-4EA3-9B78-E07E2C072E10Q45887846-7E3C949C-ED54-4D9E-88AB-70C3ED804351
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jose Carlos Segovia
@ast
Jose Carlos Segovia
@en
Jose Carlos Segovia
@es
Jose Carlos Segovia
@nl
Jose Carlos Segovia
@sl
type
label
Jose Carlos Segovia
@ast
Jose Carlos Segovia
@en
Jose Carlos Segovia
@es
Jose Carlos Segovia
@nl
Jose Carlos Segovia
@sl
prefLabel
Jose Carlos Segovia
@ast
Jose Carlos Segovia
@en
Jose Carlos Segovia
@es
Jose Carlos Segovia
@nl
Jose Carlos Segovia
@sl
P1053
L-2922-2014
P106
P21
P31
P3829
P496
0000-0003-4101-6124